Genentech Licenses Crohn's Disease GeneMap From Genizon | GenomeWeb
NEW YORK (GenomeWeb News) – Genentech has licensed Genizon Biosciences’ GeneMap of Crohn’s disease to support drug and diagnostics development, Genizon said today.
 
Under the agreement, Genizon will receive an undisclosed upfront payment, research funding, and milestone payments for each therapeutic developed through the collaboration.
 
GeneMap’s disease-associated genes were generated from a whole genome association study of 500 families from the Quebec Founder Population.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.